SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Elisabeth of Austria Synthetic CCD

PatientElisabeth of Austria
Date of birth1969-12-24
IdentifiersMRN HR-NI030-SYN; SSN (made up) 000-30-5817
Document date2026-11-01
AuthorAdelheid Marchetti-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referral. Concerns: She is frightened of gaining weight and of losing control of her body, but is exhausted and dizzy and knows she cannot go on like this; She does not want anyone, including clinic staff, to discuss her weight or her visits, and fears her illness becoming public; She cannot stay in one place for long and will be travelling for weeks at a time. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal planonce daily for 14 daysOral route2026-02-03 to 2026-02-17completedS
Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth dailyonce dailyOral route2026-02-03activeS
Potassium chloride 20 mEq extended-release tablet, one by mouth daily with food for three daysonce daily for three daysOral route2026-05-26 to 2026-05-28completedS
Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weekstwice daily with mealsOral route2026-02-10 to 2026-03-03completedS
Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a mealonce daily with a mealOral route2026-03-03activeS
Sertraline 25 mg tablet, one by mouth each morning for two weeksonce daily in the morningOral route2026-03-03 to 2026-03-17completedS
Sertraline 50 mg tablet, one by mouth each morningonce daily in the morningOral route2026-03-17activeS

Procedures

ProcedureDatesStatusEvidence
Resting twelve-lead electrocardiogram2026-02-03 to 2026-02-03completedS
Advance care planning conversation, about 20 minutes2026-03-24 to 2026-03-24completedS
Resting twelve-lead electrocardiogram2026-05-26 to 2026-05-26completedS
Dual-energy X-ray absorptiometry (DXA) of the lumbar spine and hip2026-03-03 to 2026-03-03completedS
Resting twelve-lead electrocardiogram2026-03-03 to 2026-03-03completedS

Immunizations

DateVaccineStatusEvidence
2026-03-24Recombinant zoster vaccine, dose 1 of 2completedS
2026-03-24Pneumococcal conjugate vaccine (PCV20)completedS
2026-03-24Tdap vaccinecompletedS
2026-06-30Recombinant zoster vaccine, dose 2 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
her early twentiesA prolonged illness in early adulthood with cough, poor nutrition, anemia and exhaustion, which improved with time away by the seaD (CLM-0003)
since her late teensRestrictive dieting since early adulthood, with single-food meals, a fixed upper weight of 50 kg, tight lacing to a waist of about 50 cm, and hours of walking and gymnastics every dayD (CLM-0005, CLM-0006, CLM-0007)
her fortiesGave up horse riding in her forties because of health problems not specified in the cited sourceD (CLM-0007)
recent yearsSwelling, bodily pains and sciatica in recent years, called hunger edema in letters from a spaD (CLM-0008, CLM-0010)
January 1889Mourning and deepening depression since the death of her son five years agoD (CLM-0012, CLM-0013)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
She is frightened of gaining weight and of losing control of her body, but is exhausted and dizzy and knows she cannot go on like thisactiveS
She does not want anyone, including clinic staff, to discuss her weight or her visits, and fears her illness becoming publicactiveS
She cannot stay in one place for long and will be travelling for weeks at a timeactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 12.4 on 2026-04-28; MCV [Entitic mean volume] in Red Blood Cells by Automated count 93 on 2026-02-03; Leukocytes [#/volume] in Blood by Automated count 4.4 on 2026-04-28; Platelets [#/volume] in Blood by Automated count 168 on 2026-02-03; Sodium [Moles/volume] in Serum or Plasma 138 on 2026-06-30; Potassium [Moles/volume] in Serum or Plasma 4.1 on 2026-06-30; Urea nitrogen [Mass/volume] in Serum or Plasma 24 on 2026-05-26; Creatinine [Mass/volume] in Serum or Plasma 0.78 on 2026-05-26; Glucose [Mass/volume] in Serum or Plasma 80 on 2026-03-03; Magnesium [Mass/volume] in Serum or Plasma 2 on 2026-06-30; Phosphate [Mass/volume] in Serum or Plasma 3.6 on 2026-06-30; Albumin [Mass/volume] in Serum or Plasma 4.1 on 2026-02-03; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 on 2026-04-28; Thyrotropin [Units/volume] in Serum or Plasma 2.2 on 2026-02-03; C reactive protein [Mass/volume] in Serum or Plasma 1 on 2026-02-03; Tissue transglutaminase IgA Ab [Units/volume] in Serum 0.8 on 2026-02-03; Ferritin [Mass/volume] in Serum or Plasma 64 on 2026-02-03; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 2026-06-30; Q-T interval corrected 436 on 2026-03-03; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 89 on 2026-05-26; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 on 2026-06-30; DXA Lumbar spine [T-score] Bone density -2.1 on 2026-03-03; DXA Femur [T-score] Bone density -1.8 on 2026-03-03; Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment 6.8 on 2026-03-03; Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment 1.2 on 2026-03-03 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requestedresolvedconfirmed R63.4S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation.
Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding beganactiveconfirmed F50.011S — Synthetic modern diagnosis made at the consultation, linked to her documented restrictive eating and exercise and to the retrospective diagnosis of anorexia nervosa (R).
Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intakeactiveconfirmed F33.1S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed.
Acute viral gastroenteritis, caught from a member of her travelling party, with mild dehydration, orthostatic hypotension and mild hypokalemia; no purging behavior; managed with oral rehydration and potassium; resolvedresolvedconfirmed A08.4S — Synthetic acute problem; not a historical claim.
Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fracturesactiveconfirmed M85.80S — Synthetic modern finding on DXA; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-03Hemoglobin [Mass/volume] in Blood11.2g/dL12-15.5 g/dLLowS
2026-02-03MCV [Entitic mean volume] in Red Blood Cells by Automated count93fL80-100 fLNormalS
2026-02-03Leukocytes [#/volume] in Blood by Automated count3.410*3/uL4-11 10*3/uLLowS
2026-02-03Platelets [#/volume] in Blood by Automated count16810*3/uL150-400 10*3/uLNormalS
2026-02-03Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-02-03Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
2026-02-03Urea nitrogen [Mass/volume] in Serum or Plasma21mg/dL7-20 mg/dLHighS
2026-02-03Creatinine [Mass/volume] in Serum or Plasma0.56mg/dL0.59-1.04 mg/dLLowS
2026-02-03Glucose [Mass/volume] in Serum or Plasma68mg/dL70-99 mg/dLLowS
2026-02-03Magnesium [Mass/volume] in Serum or Plasma1.8mg/dL1.7-2.2 mg/dLNormalS
2026-02-03Phosphate [Mass/volume] in Serum or Plasma3mg/dL2.5-4.5 mg/dLNormalS
2026-02-03Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
2026-02-03Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma52U/L7-35 U/LHighS
2026-02-03Thyrotropin [Units/volume] in Serum or Plasma2.2m[IU]/L0.45-4.5 mIU/LNormalS
2026-02-03C reactive protein [Mass/volume] in Serum or Plasma1mg/L<=5 mg/LNormalS
2026-02-03Tissue transglutaminase IgA Ab [Units/volume] in Serum0.8U/mLBelow 4.0 is negativeNormalS
2026-02-03Ferritin [Mass/volume] in Serum or Plasma64ng/mL15-150 ng/mLNormalS
2026-02-0325-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma22ng/mL30-100 ng/mLLowS
2026-02-03Q-T interval corrected438msAbove 460 ms is prolonged in womenNormalS
2026-02-03Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M107mL/min/{1.73_m2}60 or moreNormalS
2026-02-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]16{score}S
2026-03-24Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]13{score}S
2026-05-26Sodium [Moles/volume] in Serum or Plasma134mmol/L135-145 mmol/LLowS
2026-05-26Potassium [Moles/volume] in Serum or Plasma3.3mmol/L3.5-5.1 mmol/LLowS
2026-05-26Urea nitrogen [Mass/volume] in Serum or Plasma24mg/dL7-20 mg/dLHighS
2026-05-26Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-05-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M89mL/min/{1.73_m2}60 or moreNormalS
2026-05-26Glucose [Mass/volume] in Serum or Plasma72mg/dL70-99 mg/dLNormalS
2026-05-26Magnesium [Mass/volume] in Serum or Plasma1.7mg/dL1.7-2.2 mg/dLNormalS
2026-05-26Phosphate [Mass/volume] in Serum or Plasma3mg/dL2.5-4.5 mg/dLNormalS
2026-05-26Q-T interval corrected452msAbove 460 ms is prolonged in womenNormalS
2026-02-10Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-02-10Potassium [Moles/volume] in Serum or Plasma3.7mmol/L3.5-5.1 mmol/LNormalS
2026-02-10Glucose [Mass/volume] in Serum or Plasma74mg/dL70-99 mg/dLNormalS
2026-02-10Magnesium [Mass/volume] in Serum or Plasma1.8mg/dL1.7-2.2 mg/dLNormalS
2026-02-10Phosphate [Mass/volume] in Serum or Plasma2.3mg/dL2.5-4.5 mg/dLLowS
2026-03-03Hemoglobin [Mass/volume] in Blood11.9g/dL12-15.5 g/dLLowS
2026-03-03Leukocytes [#/volume] in Blood by Automated count3.910*3/uL4-11 10*3/uLLowS
2026-03-03Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-03-03Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.1 mmol/LNormalS
2026-03-03Glucose [Mass/volume] in Serum or Plasma80mg/dL70-99 mg/dLNormalS
2026-03-03Magnesium [Mass/volume] in Serum or Plasma1.9mg/dL1.7-2.2 mg/dLNormalS
2026-03-03Phosphate [Mass/volume] in Serum or Plasma3.2mg/dL2.5-4.5 mg/dLNormalS
2026-03-03Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-35 U/LHighS
2026-03-03Q-T interval corrected436msAbove 460 ms is prolonged in womenNormalS
2026-03-03DXA Lumbar spine [T-score] Bone density-2.1{T-score}-1.0 or higher is normal; -2.5 or lower is osteoporosisLowS
2026-03-03DXA Femur [T-score] Bone density-1.8{T-score}-1.0 or higher is normal; -2.5 or lower is osteoporosisLowS
2026-03-03Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment6.8%S
2026-03-03Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment1.2%S
2026-03-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
2026-04-28Hemoglobin [Mass/volume] in Blood12.4g/dL12-15.5 g/dLNormalS
2026-04-28Leukocytes [#/volume] in Blood by Automated count4.410*3/uL4-11 10*3/uLNormalS
2026-04-28Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-04-28Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
2026-04-28Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.2 mg/dLNormalS
2026-04-28Phosphate [Mass/volume] in Serum or Plasma3.4mg/dL2.5-4.5 mg/dLNormalS
2026-04-28Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-35 U/LNormalS
2026-04-28Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S
2026-06-30Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-06-30Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-06-30Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.2 mg/dLNormalS
2026-06-30Phosphate [Mass/volume] in Serum or Plasma3.6mg/dL2.5-4.5 mg/dLNormalS
2026-06-3025-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
2026-06-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-02-03Body height172cmS
2026-02-03Body weight47.4kgS
2026-02-03Body mass index (BMI) [Ratio]16kg/m2S
2026-02-03Systolic blood pressure96mm[Hg]S
2026-02-03Diastolic blood pressure62mm[Hg]S
2026-02-03Heart rate52/minS
2026-02-03Respiratory rate14/minS
2026-02-03Body temperature36CelS
2026-02-03Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-02-10Body height172cmS
2026-02-10Body weight47.9kgS
2026-02-10Body mass index (BMI) [Ratio]16.2kg/m2S
2026-02-10Systolic blood pressure98mm[Hg]S
2026-02-10Diastolic blood pressure62mm[Hg]S
2026-02-10Heart rate54/minS
2026-02-10Respiratory rate14/minS
2026-02-10Body temperature36.1CelS
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-03-03Body height172cmS
2026-03-03Body weight49.6kgS
2026-03-03Body mass index (BMI) [Ratio]16.8kg/m2S
2026-03-03Systolic blood pressure100mm[Hg]S
2026-03-03Diastolic blood pressure64mm[Hg]S
2026-03-03Heart rate56/minS
2026-03-03Respiratory rate14/minS
2026-03-03Body temperature36.2CelS
2026-03-03Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-04-28Body height172cmS
2026-04-28Body weight52kgS
2026-04-28Body mass index (BMI) [Ratio]17.6kg/m2S
2026-04-28Systolic blood pressure104mm[Hg]S
2026-04-28Diastolic blood pressure66mm[Hg]S
2026-04-28Heart rate60/minS
2026-04-28Respiratory rate14/minS
2026-04-28Body temperature36.4CelS
2026-04-28Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-30Body height172cmS
2026-06-30Body weight54kgS
2026-06-30Body mass index (BMI) [Ratio]18.3kg/m2S
2026-06-30Systolic blood pressure106mm[Hg]S
2026-06-30Diastolic blood pressure68mm[Hg]S
2026-06-30Heart rate62/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.5CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-03-24Body height172cmS
2026-03-24Body weight50.4kgS
2026-03-24Body mass index (BMI) [Ratio]17kg/m2S
2026-03-24Systolic blood pressure100mm[Hg]S
2026-03-24Diastolic blood pressure64mm[Hg]S
2026-03-24Heart rate58/minS
2026-03-24Respiratory rate14/minS
2026-03-24Body temperature36.3CelS
2026-03-24Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-26Body height172cmS
2026-05-26Body weight51kgS
2026-05-26Body mass index (BMI) [Ratio]17.2kg/m2S
2026-05-26Systolic blood pressure96mm[Hg]S
2026-05-26Diastolic blood pressure60mm[Hg]S
2026-05-26Heart rate74/minS
2026-05-26Respiratory rate16/minS
2026-05-26Body temperature37.6CelS
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-02-03New patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referralfinishedS
2026-02-10One-week medical stabilization check and eating disorders psychiatry consultationfinishedS
2026-03-03Four-week review: weight, vital signs, electrolytes, bone density, and depressionfinishedS
2026-04-28Twelve-week review: weight restoration, exercise, mood and sertralinefinishedS
2026-06-30Twenty-one-week review: weight, mood, the gastroenteritis, and care while travellingfinishedS
2026-03-24Periodic adult preventive visitfinishedS
2026-05-26Same-day sick visit for vomiting and diarrheafinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Eating disorders psychiatry consultation in one week to confirm the diagnosis, decide the level of care, and lead a multidisciplinary plancompletedGL-APA-ED-2023, GL-AED-MCS-2021S
Medical assessment and stabilization: orthostatic vital signs and temperature, ECG, blood count, electrolytes with phosphate and magnesium, glucose, kidney and liver tests, albumin, TSH, CRP, ferritin and vitamin D; admission criteria explained; electrolytes, phosphate and magnesium to be rechecked three to four days after the meal plan starts, then weekly for the first weekscompletedGL-APA-ED-2023, GL-SAHM-ED-2022, GL-AED-MCS-2021S
Refeeding risk: thiamine 100 mg daily before and during the first two weeks, and a starting meal plan of about 1,600 kcal a day in three meals and two snacks, increased by about 200 to 300 kcal every few dayscompletedGL-ASPEN-REFEED-2020, GL-SAHM-ED-2022S
Collaborative safety plan with warning signs, coping steps, people to contact including her travelling companion, the clinic number, the 988 Suicide & Crisis Lifeline and local emergency numbers abroad; medicines dispensed in small supplies and kept by her companioncompletedGL-SUICIDE-2024S
Privacy: the chart is flagged as restricted, access is audited, she is booked under a scheduling alias at the first or last appointment of the day, and weights are discussed only in the consulting roomcompletedGL-APA-ED-2023S
Multidisciplinary outpatient treatment: weekly CBT-E with an eating disorders therapist, a dietitian twice a month, medical review by the primary clinician, and psychiatry review; open weighing at sessions instead of weighing at home; by video when she travelscompletedGL-APA-ED-2023, GL-NICE-NG69S
Compulsive exercise: no gymnastics and walks of no more than an hour a day while weight is restored and the pulse and orthostatic changes are abnormal, with a graded return agreed by the teamcompletedGL-APA-ED-2023, GL-SAHM-ED-2022S
Bone health: DXA of the spine and hip, calcium 1,200 mg a day from food and supplement, vitamin D, weight restoration as the main treatment, and repeat DXA in two yearscompletedGL-CMID-2026, GL-USPSTF-OST-2025, GL-APA-ED-2023S
Depression with persistent grief: grief-focused work within therapy; sertraline 25 mg daily, increased to 50 mg after two weeks, once nutrition was under way and the QTc was normal; PHQ-9 at every visit and suicide-risk review at every visitcompletedGL-CMID-2026, GL-MDD-2022, GL-SUICIDE-2024S

Goals

GoalTargetStatusOutcomeProvenance
Medically stable for outpatient care: resting pulse 50 or more, no orthostatic dizziness, and normal potassium, phosphate, magnesium and glucose2026-03-03completedPulse 56, orthostatic changes resolved, electrolytes and glucose normal at four weeksS
Weight gain of about 0.5 to 1 kg a week toward a body mass index of at least 18.52026-08-31activeFrom 47.4 kg (BMI 16.0) to 54.0 kg (BMI 18.3) at twenty-one weeks; still gainingS
Depression response (PHQ-9 down by at least 50 percent) by six months2026-06-30completedPHQ-9 7 at twenty-one weeks, down 56 percent from 16S
Exercise reduced to walks of an hour or less a day while weight is restored, with no gymnastics until the team agrees2026-04-28completedWalks of about an hour a day; gymnastics stoppedS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-02-03: current ideation present, intent absent, plan absent. Passive thoughts of death without intent, plan or past attempts; outpatient care with a collaborative safety plan that works when she travels, the 988 Suicide & Crisis Lifeline and local emergency numbers abroad, medicines dispensed in small supplies, and review at one week [S]